Yumanity Therapeutics Overview
- Year Founded
-
2014

- Status
-
Acquired/Merged
- Employees
-
8

- Latest Deal Type
-
M&A
- Investors
-
3
Yumanity Therapeutics General Information
Description
Developer of transformative brain-penetrating small molecule drugs designed for the treatment of neurodegenerative diseases caused by protein misfolding. The company is focused on the discovery and development of innovative, disease-modifying therapies for patients with Parkinson's disease and related disorders, amyotrophic lateral sclerosis and Alzheimer's disease.
Contact Information
Website
www.yumanity.comCorporate Office
- 40 Guest Street
- Suite 4410
- Boston, MA 02135
- United States
Corporate Office
- 40 Guest Street
- Suite 4410
- Boston, MA 02135
- United States
Yumanity Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
12. Merger/Acquisition | 16-Dec-2022 | Completed | Generating Revenue | |||
11. PIPE | 06-Dec-2022 | Completed | Generating Revenue | |||
10. PIPE | 22-Dec-2020 | Completed | Generating Revenue | |||
9. Reverse Merger | 22-Dec-2020 | Completed | Generating Revenue | |||
8. Later Stage VC (Series C) | 24-Jun-2020 | Completed | Generating Revenue | |||
7. Debt - PPP | 14-Apr-2020 | Completed | Generating Revenue | |||
6. Mezzanine | 31-Dec-2019 | Completed | Generating Revenue | |||
5. Early Stage VC | 29-Jun-2018 | Completed | Generating Revenue | |||
4. Early Stage VC (Series A) | 18-Feb-2016 | $51M | $51M | Completed | Startup | |
3. Accelerator/Incubator | 01-Jan-2016 | Completed | Startup |
Yumanity Therapeutics Comparisons
Industry
Financing
Details
Yumanity Therapeutics Competitors (42)
One of Yumanity Therapeutics’s 42 competitors is SAGE Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
SAGE Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
Bioasis Technologies | Corporation | Guilford, CT | ||||
ProMIS Neurosciences | Corporation | Toronto, Canada | ||||
CuraSen | Venture Capital-Backed | San Carlos, CA | ||||
ALSP | Venture Capital-Backed | San Diego, CA |
Yumanity Therapeutics Signals
Yumanity Therapeutics Former Investors (11)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Alexandria Venture Investments | Venture Capital | Minority | ||
Biogen | Corporation | Minority | ||
Dolby Family Ventures | Venture Capital | Minority | ||
Fidelity Management & Research Company | Asset Manager | Minority | ||
Hercules Capital | Lender/Debt Provider | Minority |
Yumanity Therapeutics Acquisitions (2)
Yumanity Therapeutics’s most recent deal was a Reverse Merger with Kineta for . The deal was made on 16-Dec-2022.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
---|---|---|---|---|---|
Kineta | 16-Dec-2022 | Reverse Merger | Drug Discovery | ||
Proteostasis Therapeutics | 22-Dec-2020 | Merger/Acquisition | Drug Discovery |
Yumanity Therapeutics ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile

Pharmaceuticals
Industry
Rank
Percentile

Pharmaceuticals
Subindustry
Rank
Percentile

Yumanity Therapeutics FAQs
-
When was Yumanity Therapeutics founded?
Yumanity Therapeutics was founded in 2014.
-
Where is Yumanity Therapeutics headquartered?
Yumanity Therapeutics is headquartered in Boston, MA.
-
What is the size of Yumanity Therapeutics?
Yumanity Therapeutics has 8 total employees.
-
What industry is Yumanity Therapeutics in?
Yumanity Therapeutics’s primary industry is Drug Discovery.
-
Is Yumanity Therapeutics a private or public company?
Yumanity Therapeutics is a Private company.
-
What is Yumanity Therapeutics’s current revenue?
The current revenue for Yumanity Therapeutics is
. -
How much funding has Yumanity Therapeutics raised over time?
Yumanity Therapeutics has raised $1.45B.
-
Who are Yumanity Therapeutics’s investors?
Alexandria Venture Investments, Biogen, Dolby Family Ventures, Fidelity Management & Research Company, and Hercules Capital are 5 of 11 investors who have invested in Yumanity Therapeutics.
-
Who are Yumanity Therapeutics’s competitors?
SAGE Therapeutics, Bioasis Technologies, ProMIS Neurosciences, CuraSen, and ALSP are some of the 42 competitors of Yumanity Therapeutics.
-
When was Yumanity Therapeutics acquired?
Yumanity Therapeutics was acquired on 16-Dec-2022.
-
Who acquired Yumanity Therapeutics?
Yumanity Therapeutics was acquired by Kineta and DGP Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »